Biocon net down 42% quarterly, 17% yearly

Written by MD Bureau Published On 2020-05-15T20:45:46+05:30 | Updated On 16 May 2020 11:33 AM IST

Biocon net down 42% quarterly, 17% yearly

Bengaluru, May 15 (IANS) Leading biotechnology firm Biocon reported Rs 123 crore consolidated net profit for the fourth quarter (Q4) of fiscal 2019-20, registering a 42 per cent annual decline from Rs 214 crore posted in the same period a year ago.

"Consolidated net profit for the fiscal 2019-20 also declined 17 per cent to Rs 748 crore from Rs 905 crore in the previous fiscal (2018-19)," said the city-based company in a regulatory filing on the BSE on Friday.

Consolidate revenue from operations for the quarter (Q4) under review, however, grew 3 per cent annually to Rs 1,581 crore from Rs 1,529 crore in the like period a year ago.

"For the fiscal (FY2020), operational revenue increased 15 per cent to Rs 6,367 crore from Rs 5,514 crore in the previous fiscal," it added.

Earnings before interest, tax, depreciation and amortization of assets (Ebitda) for the quarter also declined 11 per cent to Rs 382 crore from Rs 431 crore a year ago, but increased 15 per cent annually for the fiscal to Rs 1,765 crore from Rs 1,538 crore a year ago.

--IANS

fb/vd

bioconnetkiran-mazumdar-shaw

Source : IANS

MD Bureau

Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.